Cargando…
Cetuximab for esophageal cancer: an updated meta-analysis of randomized controlled trials
BACKGROUND: Increasing evidence indicates that cetuximab (CET) combined with chemoradiotherapy may be effective for patients with esophageal cancer. However, the recent results are still contradictory and no consensus has yet been reached on this issue. To evaluate the clinical effects and safety of...
Autores principales: | Huang, Ze-Hao, Ma, Xiao-Wen, Zhang, Jing, Li, Xiao, Lai, Na-Lin, Zhang, Sheng-Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258395/ https://www.ncbi.nlm.nih.gov/pubmed/30477458 http://dx.doi.org/10.1186/s12885-018-5040-z |
Ejemplares similares
-
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial
por: Lu, Zhihao, et al.
Publicado: (2022) -
The Proportion of Regulatory T Cells in Patients with Systemic Lupus Erythematosus: A Meta-Analysis
por: Zhang, Sheng-Xiao, et al.
Publicado: (2018) -
A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide
por: Liu, Xiaopei, et al.
Publicado: (2022) -
The effect of erythropoietin on neonatal hypoxic-ischemic encephalopathy: An updated meta-analysis of randomized control trials
por: Pan, Jing-Jing, et al.
Publicado: (2023) -
Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
por: Yang, Ying-nan, et al.
Publicado: (2018)